4DMedicalASX:4DX -8.97%64 Days Payable is 2,356.21 as of Dec. 2025, which is 32% below its 10-year median of 3,467.69. GuruFocus rates ASX:4DX with a GF Score™ of 64/100 and a GF Value™ of A$1.44 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, 4DMedical ranks better than 97.61% on this metric.
4DMedical's average Accounts Payable for the
six
months ended in Dec. 2025 was A$2.53 Mil. 4DMedical's Cost of Goods Sold for the
six
months ended in Dec. 2025 was A$0.20 Mil.
Hence, 4DMedical's Days Payable for the
six
months ended in Dec. 2025 was 2,356.21.
The historical rank and industry rank for 4DMedical's Days Payable or its related term are showing as below:
ASX:4DX'
s Days Payable Range Over the Past 10 Years
Min: 533.1 Med: 3467.69 Max: 25088.38
Current: 2719.46
During the past 6 years, 4DMedical's highest Days Payable was 25088.38. The lowest was 533.10. And the median was 3467.69.
ASX:4DX's Days Payable is ranked better than 97.61% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs ASX:4DX: 2719.46
4DMedical's Days Payable
declined
from Dec. 2024 (5,138.15) to Dec. 2025 (2,356.21).
It may suggest that 4DMedicalaccelerated paying its suppliers.
4DMedical Days Payable Related Terms
4DMedical Days Payable Historical Data
* Premium members only.
The historical data trend for 4DMedical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 4DMedical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Days Payable distribution charts can be found below:
* The bar in red indicates where 4DMedical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
4DMedical's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4DMedical (ASX:4DX) has a Days Payable of 2,356.21 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 4DMedical and its competitors. This is 32% below median its historical median of 3,467.69. Over the past decade, 4DMedical's Days Payable has ranged from 533.10 to 25,088.38. According to the industry distribution chart, 4DMedical ranks #19 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 2.4%.
Is 4DMedical's Days Payable too high?
4DMedical's current Days Payable of 2,356.21 is 32% below median its 10-year median of 3,467.69. Over the past 10 years, this metric has ranged from a low of 533.10 to a high of 25,088.38. The Medical Devices & Instruments industry median Days Payable is 67.87. 4DMedical's value of 2,356.21 is 3371.7% above this industry median. Based on the distribution chart, 4DMedical ranks #19 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, 4DMedical has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 4DMedical ranks #19 out of 795 companies for Days Payable. This places 4DMedical in the top 2% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. 4DMedical's value of 2,356.21 is 3371.7% above this benchmark. Historically, 4DMedical's own Days Payable has ranged from 533.10 to 25,088.38 over the past decade. While the company's 10-year median is 3,467.69 vs. the industry median of 67.87, 4DMedical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 4DMedical's current Days Payable of 2,356.21 is 3371.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 4DMedical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4DMedical's current Days Payable is 2,356.21, which is 32% below median its own 10-year median of 3,467.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (ASX:4DX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$1.44, compared to a current price of A$4.16 — trading 188.9% above its estimated fair value. The current Days Payable is 2,356.21, which is 32% below median its 10-year median of 3,467.69 and 3371.7% above the Medical Devices & Instruments industry median of 67.87. 4DMedical's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For 4DMedical (ASX:4DX), the current Days Payable is 2,356.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4DMedical (ASX:4DX) Overvalued in 2026?
Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued.
The current stock price of A$4.16 is trading 188.9% above its estimated GF Value™ of A$1.44.
GuruFocus considers 4DMedical to be Significantly Overvalued.
Key valuation signals for ASX:4DX:
Days Payable: 2,356.21 (32% below median its 10-year median of 3,467.69)
GF Value™: A$1.44 vs. price of A$4.16 (188.9% above fair value)
Industry Position: 3371.7% above the Medical Devices & Instruments median (#19 of 795)
No single metric tells the full story. See the ASX:4DX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
64GF Score
Get the complete analysis for ASX:4DX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:4DX has been successfully added to your 
